>> 全站文章索引 >> 第26页:
  • Effect of gender on antinociceptive effect of paroxetine in hot plate test in mice - [Erdem N. Duman, Murat Kesim, Mine Kadioglu, Cunay Ulku, Nuri I. Kalyoncu and Ersin Yaris]
  • A Comparison of the Chronic Treatment Effects of Venlafaxine and Other Antidepressants on Serotonin and Norepinephrine Transporters - [Georgianna G. Gould, Alfonso V. Altamirano, Martin A. Javors and Alan Frazer]
  • Effects of paroxetine and venlafaxine on immune parameters in patients with obsessive compulsive disorder - [Damiaan Denys, Sjoerd Fluitman, Annemieke Kavelaars, Cobi Heijnen and Herman G.M. Westenberg]
  • A comparison of in vivo and in vitro neuroimaging of 5-HT1A receptor binding sites in the cat brain - [Nicolas Aznavour, Latifa Rbah, Lucienne Léger, Colette Buda, Jean-Pierre Sastre, Anouk Imhof, Yves Charnay and Luc Zimmer]
  • T3 augmentation of SSRI resistant depression - [Gebrehiwot Abraham, Roumen Milev and J. Stuart Lawson]
  • The impact of CYP2D6 genotypes on the plasma concentration of paroxetine in Japanese psychiatric patients - [Mikito Ueda, Genta Hirokane, Sachiyo Morita, Masako Okawa, Takashi Watanabe, Kazufumi Akiyama and Kazutaka Shimoda]
  • Treatment of bereavement-related depression and traumatic grief - [Paula L. Hensley]
  • The spermicidal and antitrichomonas activities of SSRI antidepressants - [V.S. Kiran Kumar S.T., Vishnu Lal Sharma, Pratibha Tiwari, Divya Singh, Jagdamba Prasad Maikhuri, Gopal Gupta and Man Mohan Singh]
  • Determination of pharmaceuticals of various therapeutic classes by solid-phase extraction and liquid chromatography–tandem mass spectrometry analysis in hospital effluent wastewaters - [M. José Gómez, Mira Petrovi?, Amadeo R. Fernández-Alba and Damià Barceló]
  • Co-catalyzed reductive cyclization of azido and cyano substituted α,β-unsaturated esters with NaBH4: enantioselective synthesis of ?-baclofen and ?-rolipram - [Abhimanyu S. Paraskar and Arumugam Sudalai]
  • Selective serotonin reuptake inhibitors in sewage influents and effluents from Troms?, Norway - [Terje Vasskog, Urs Berger, Per-Jostein Samuelsen, Roland Kallenborn and Einar Jensen]
  • Risperidone in the treatment of psychotic depression - [Makiko Goto, Reiji Yoshimura, Shingo Kakihara, Koji Shinkai, Yasuhisa Yamada, Kyoko Kaji, Nobuhisa Ueda and Jun Nakamura]
  • Partial lesion of the serotonergic system by a single dose of MDMA results in behavioural disinhibition and enhances acute MDMA-induced social behaviour on the social interaction test - [Romeo D. Ando, Anita Benko, Linda Ferrington, Eszter Kirilly, Paul A.T. Kelly and Gyorgy Bagdy]
  • Gene expression and association analysis of LIM (PDLIM5) in major depression - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Ikuyo Motoki, Sumiko Tayoshi, Sawako Kinouchi, Koshi Ohta, Hongwei Song, Kyoko Morita, et al.]
  • Usefulness of Paroxetine in Depressed Men With Paroxysmal Atrial Fibrillation - [Takeshi Shirayama, Takashi Sakamoto, Tomohiko Sakatani, Hiroki Mani, Taku Yamamoto and Hiroaki Matsubara]
  • Reduced platelet [3H]paroxetine binding in anorexia nervosa: Relationship to eating symptoms and personality pathology - [Kenneth R. Bruce, Howard Steiger, N.M.K. Ng Ying Kin and Mimi Israel]
  • Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa - [Agneta Ekman, Charlotta Sundblad-Elverfors, Mikael Landén, Tomas Eriksson and Elias Eriksson]
  • Paroxetine treatment of compulsive hoarding - [Sanjaya Saxena, Arthur L. Brody, Karron M. Maidment and Jr., Lewis R. Baxter]
  • Prognosis of Patients Taking Selective Serotonin Reuptake Inhibitors Before Coronary Artery Bypass Grafting - [Glen L. Xiong, Wei Jiang, Robert Clare, Linda K. Shaw, Peter K. Smith, Kenneth W. Mahaffey, Christopher M. O’Connor, K. Ranga R. Krishnan and L. Kristin Newby]
  • The four-plates test: Anxiolytic or analgesic paradigm? - [Nadège Ripoll, Martine Hasco?t and Michel Bourin]
  • Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety - [Sandy Hogg, Line Michan and Maria Jessa]
  • Gender differences in response to antidepressant treatment prescribed in primary care. Does menopause make a difference? - [Alejandra Pinto-Meza, Judith Usall, Antoni Serrano-Blanco, David Suárez and Josep Maria Haro]
  • Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive–behavioral treatment in patients with bulimia nervosa - [Muneki Tanaka, Toshihiro Nakahara, Tetsuro Muranaga, Shinya Kojima, Daisuke Yasuhara, Hiroaki Ueno, Masamitsu Nakazato and Akio Inui]
  • Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test - [Fernando T. Consoni, Maria A.B.F. Vital and Roberto Andreatini]
  • Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers - [Ellen R.A. de Bruijn, Bernard G.C. Sabbe, Wouter Hulstijn, Gé S.F. Ruigt and Robbert J. Verkes]
  • Possible neuroleptic malignant syndrome related to concomitant treatment with paroxetine and alprazolam - [isashi Tanii, Kayo Ichihashi, Ken Inoue, Kohei Fujita and Yuji Okazaki]
  • Serotonin and Premature Ejaculation: From Physiology to Patient Management - [Fran?ois Giuliano and Pierre Clément]
  • Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial - [D.G.S. Perahia, F. Wang, C.H. Mallinckrodt, D.J. Walker and M.J. Detke]
  • Major depressive disorders: clinical efficacy and tolerability of agomelatine, a new melatonergic agonist - [Stuart A. Montgomery]
  • Antidepressant therapy in tinnitus - [Shannon K. Robinson, Erik S. Viirre and Murray B. Stein]
  • Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test - [F. Chenu, B.P. Guiard, M. Bourin and A.M. Gardier]
  • Electroanalytical determination of paroxetine in pharmaceuticals - [Henri P.A. Nouws, Cristina Delerue-Matos, Aquiles A. Barros and José A. Rodrigues]
  • Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine - [Paul D. Callaghan, Kirsten Farrand, Abdallah Salem, Patrick Hughes, Lynette C. Daws and Rodney J. Irvine]
  • Effects of olanzapine on aggressiveness in heroin dependent patients - [G. Gerra, G. Di Petta, A. D]
  • Personality disorders and response to medication treatment in panic disorder: A 1-year naturalistic study - [Carlo Marchesi, Chiara De Panfilis, Alessandro Cantoni, Stefania Fontò, Maria R. Giannelli and Carlo Maggini]
  • Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension - [Steven M. Kawut, Evelyn M. Horn, Ketevan K. Berekashvili, David J. Lederer, Allison C. Widlitz, Erika B. Rosenzweig and Robyn J. Barst]
  • Paroxetine treatment improves motor symptoms in patients with multiple system atrophy - [Elisabeth Friess, Tania Kuempfel, Sieglinde Modell, Juliane Winkelmann, Florian Holsboer, Marcus Ising and Claudia Trenkwalder]
  • Antidepressant withdrawal symptoms—Telephone calls to a national medication helpline - [David Taylor, Suzanne Stewart and Anne Connolly]
  • Solid-phase extraction and analysis of 20 antidepressant drugs in human plasma by LC/MS with SSI method - [Tatsuo Shinozuka, Masaru Terada and Einosuke Tanaka]
  • Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: A multi-level, single-sample approach - [H. Kirchherr and W.N. Kühn-Velten]
  • Effects of amantadine and budipine on antidepressant drug-evoked changes in extracellular dopamine in the frontal cortex of freely moving rats - [Jenny C.E. Owen and Peter S. Whitton]
  • Differential effects of antidepressants on dexamethasone-induced nuclear translocation and expression of glucocorticoid receptor - [Hiromasa Funato, Ayumi Kobayashi and Yoshifumi Watanabe]
  • Pregnancy outcomes following exposure to serotonin reuptake inhibitors: a meta-analysis of clinical trials - [Roja Rahimi, Shekoufeh Nikfar and Mohammad Abdollahi]
  • Prediction of treatment response by HPA-axis and glucocorticoid receptor polymorphisms in major depression - [Jantien P. Brouwer, Bente C. Appelhof, Elisabeth F.C. van Rossum, Jan W. Koper, Eric Fliers, Jochanan Huyser, Aart H. Schene, Jan G.P. Tijssen, Richard Van Dyck, Steven W.J. Lamberts, et al.]
  • Enantioselective total and formal syntheses of paroxetine (PAXIL) via phosphine-catalyzed enone α-arylation using arylbismuth(V) reagents: a regiochemical complement to Heck arylation - [Phillip K. Koech and Michael J. Krische]
  • Traitement d'une intoxication à l'hydroxychloroquine par circulation extracorporelle - [F. Mongenot, Y. Tessier Gonthier, F. Derderian, M. Durand and D. Blin]
  • A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from Protium heptaphyllum (Aubl.) March - [G.F. Arag?o, L.M.V. Carneiro, A.P.F. Junior, L.C. Vieira, P.N. Bandeira, T.L.G. Lemos and G.S. de B. Viana]
  • Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: Evidence for synergism between serotonergic and noradrenergic reuptake inhibition - [Carrie K. Jones, Brian J. Eastwood, Anne B. Need and Harlan E. Shannon]
  • Reversal of learned helplessness by selective serotonin reuptake inhibitors in rats is not dependent on 5-HT availability - [Arturo Zazpe, Inés Artaiz, Luis Labeaga, María Luisa Lucero and Aurelio Orjales]
  • Perospirone augmentation of paroxetine in treatment of refractory obsessive–compulsive disorder with depression - [Tatsui Otsuka, Takashi Togo, Naoya Sugiyama, Kumi Uehara, Asuka Yoshimi, Aya Karashima, Hiromi Shioya and Yoshio Hirayasu]
  • Stir bar sorptive extraction and liquid chromatography with UV detection for determination of antidepressants in plasma samples - [Andréa Rodrigues Chaves, Silvana Maciel Silva, Regina Helena Costa Queiroz, Fernando Mauro Lan?as and Maria Eugênia Costa Queiroz]
  • Gene expression and association analysis of vascular endothelial growth factor in major depressive disorder - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sumiko Tayoshi-Shibuya, Sawako Kinouchi, Masahito Nakataki, Hongwei Song, Kazuhiko Hokoishi, Hirotaka Tanabe, et al.]
  • Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Shusuke Numata, Sawako Kinouchi, Sumiko Tayoshi-Shibuya, Hongwei Song and Tetsuro Ohmori]
  • Blood–brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls - [Manfred Uhr, Markus T. Grauer, Alexander Yassouridis and Martin Ebinger]
  • Effect of Chronic Administration of Duloxetine on Serotonin and Norepinephrine Transporter Binding Sites in Rat Brain - [Georgianna G. Gould, Martin A. Javors and Alan Frazer]
  • Altered Brain Activation Pattern Associated With Drug-Induced Attenuation of Enhanced Depression-Like Behavior in Rats Bred for High Anxiety - [Patrik Muigg, Ulrike Hoelzl, Klara Palfrader, Inga Neumann, Alexandra Wigger, Rainer Landgraf and Nicolas Singewald]
  • Effects of acute fluoxetine, paroxetine and desipramine on rats tested on the elevated plus-maze - [Dominique Drapier, Danièle Bentué-Ferrer, Bruno Laviolle, Bruno Millet, Hervé Allain, Michel Bourin and Jean-Michel Reymann]
  • Serotonin syndrome in a case of depression with various somatic symptoms: The difficulty in differential diagnosis - [Takeshi Terao and Takatoshi Hikichi]
  • Basilar artery blood flow velocity changes in patients with panic disorder following 35% carbon dioxide challenge - [Tun? Alk?n, ümit Tural, Elif Onur, Vesile ?ztürk, E. Serap Monkul and Kür?ad Kutluk]
  • Paroxetine-induced apoptosis in human osteosarcoma cells: Activation of p38 MAP kinase and caspase-3 pathways without involvement of [Ca2+]i elevation - [Chiang-Ting Chou, Shiping He and Chung-Ren Jan]
  • Emergence, persistence, and resolution of suicidal ideation during treatment of depression in old age - [Katalin Szanto, Benoit H. Mulsant, Patricia R. Houck, Mary Amanda Dew, Alexandre Dombrovski, Bruce G. Pollock and Charles F. Reynolds III]
  • Effect of antidepressant drugs on 6-OHDA-treated mice in the FST - [F. Chenu, E. Dailly and M. Bourin]
  • Neuronal proteins involved in synaptic targeting of AMPA receptors in rat hippocampus by antidepressant drugs - [Rebeca Martínez-Turrillas, Joaquín Del Río and Diana Frechilla]
  • Antipsychotics inhibit TREK but not TRAAK channels - [Susanne Thümmler, Fabrice Duprat and Michel Lazdunski]
  • Resistin and adiponectin in major depression: The association with free cortisol and effects of antidepressant treatment - [Bettina Weber-Hamann, Jürgen Kratzsch, Daniel Kopf, Florian Lederbogen, Maria Gilles, Isabella Heuser and Michael Deuschle]
  • The challenge of depression in late life: Bridging science and service in primary care - []
  • Treating major depression in primary care practice: An update of the agency for health care policy and research practice guidelines - [Dr. H.C. Schulberg, Western Psychiatric Inst. and Clinic, 3811 O'Hara St, Pittsburgh, PA 15213; United States. E-Mail: schulbergh@msx.upmc.edu.]
  • Stepped collaborative care for primary care patients with persistent symptoms of depression: A randomized trial - [Dr. W. Katon, Department of Psychiatry, Univ. of Washington School of Med., Box 35-6560, Seattle, WA 98195; United States. E-Mail: wkaton@u.washington.edu.]
  • Impact of a collaborative pharmacy practice model on the treatment of depression in primary care - [Dr. P.R. Finley, Univ. of California at San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0622; United States.]
  • Diagnosis and management of depression in primary care: A clinical update and review - [Dr. R.A. Remick, Department of Psychiatry, St. Paul]
  • A Review of Postpartum Depression for the Primary Care Physician - [Dr. D.A. Seehusen, Department of Family Practice, Madigan Army Medical Center, Ft. Lewis, WA 98431; United States. E-Mail: dean.seehusen@nw.amedd.army.mil.]
  • Response, partial response, and nonresponse in primary care treatment of depression - [Dr. R. Swindle, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285; United States. E-Mail: swindle@lilly.com.]
  • Prevalence and predictors of depression treatment in an international primary care study - [Dr. G.E. Simon, Center for Health Studies, 1730 Minor Ave., Number 1600, Seattle, WA 98101; United States. E-Mail: simon.g@ghc.org.]
  • A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group - [Department of Psychiatry and Pharmacology, University of Ottawa, Ontario, Canada.]
  • Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care - [Oxford University Department of Psychiatry, Warneford Hospital, Oxford OX3 7BJ. lmmw@soton.ac.uk]
  • Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults.[see comment] - [Ambulatory Care (11C-6), 7400 Merton Minter Blvd, San Antonio, TX 78284, USA. jwilliam@verdict.uthscsa.edu]
  • Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.[see comment] - [Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH 03755, USA. James.Barrett@Dartmouth.edu]
  • Response styles among patients with minor depression and dysthymia in primary care - [College of Health Sciences, University of Texas at El Paso, 79902, USA. schmaling@utep.edu]
  • Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression - [Department of Psychiatry, University of Washington, Seattle 98195, USA.]
  • A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care - [Community Pharmacology Services Ltd (CPS), Clydebank, Glasgow, UK. cps@cpsresearch.co.uk]
  • Impact of pain on depression treatment response in primary care - [Regenstrief Institute and the Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA. mbair@regenstrief.org]
  • The cost-effectiveness of mirtazapine versus paroxetine in treating people with depression in primary care - [Centre for the Economics of Mental Health, Health Services Research Department, Institute of Psychiatry, King]
  • Abstracts of the European Association of Poisons Centres and Clinical Toxicologists XXIII International Congress - [.]
  • Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose - [Geoffrey K. Isbister, Steven J. Bowe, Andrew Dawson, et al.]
  • Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors - [H. Nordeng, R. Lindemann, K. V. Perminov, . Reikvam1]
  • Cocaine-associated stroke: three cases and rehabilitation considerations - [Raj D. Tolat, Michael W. O]
  • A REVERSED-PHASE HPLC METHOD DEVELOPMENT FOR THE SEPARATION OF NEW ANTIDEPRESSANTS - [P. Dallet, L. Labat, M. Richard, et al.]
  • Drug Metabolism Reviews 201-300 - [.]
  • Abstracts of the 2003 North American Congress of Clinical Toxicology Annual Meeting - [.]
  • Drug Metabolism Reviews 301-400 - [.]
  • A Depressed Myocardium - [Samuel J. Partridge, David H. MacIver, Tarun Solanki]
  • Paroxetine during lactation: is it really safe for the infant - [TW de Vries, LTW de Jong-van de Berg, M Hadders-Algra]
  • Paroxetine Use Throughout Pregnancy: Does It Pose Any Risk to the Neonate - [Iris Morag, D. Batash, R. Keidar, et al.]
  • Paroxetine versus citalopram treatment of pathological crying after brain injury - [Ulrich Muller, Toshiya Murai, Thomas Bauer-Wittmund, D. Yves Von Cramon]
  • Post-Stroke Depression: Relationships to Functional Impairment, Coping Strategies, and Rehabilitation Outcome - [SINYOR, D. AVID; AMATO, P. HYLLIS; KALOUPEK, D. ANNY; BECKER, R. UBIN; GOLDENBERG, M. ARVIN; COOPERSMITH, H. ENRY]
  • ECT for Post-stroke Depression: Beta Blockade to Modify Rise in Blood Pressure - [Allman, Peter M.; Hawton, Keith D.]
  • Post-Stroke Depression in Primary Support Persons: Predicting Those at Risk - [Tompkins, Connie A.; Schulz, Richard; Rau, Marie T.]
  • Comparison of Six Depression Rating Scales in Geriatric Stroke Patients - [Agrell, Berit M.; Dehlin, Ove M.]
  • Dementia of Depression in Parkinson's Disease and Stroke - [STARKSTEIN, S. EEGIO; ROBINSON, R. OBERT]
  • Lesion Location and Depression in Hospitalized Stroke Patients - [Morris, Philip L.; Robinson, Robert G.; Raphael, Beverley M.]


  • 分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 [26] 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50